ArticleInternational journal of surgery (London, England)2026
Effect of occlusion site on the effectiveness and safety of endovascular thrombectomy for large ischemic cores: a cohort study.
Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Educational value of remote live-streamed training in endovascular thrombectomy: dose-response and mediation analysis.Journal of neurointerventional surgery · 2026Article
- CTA imaging characteristics and endovascular therapy effect in patients with large ischemic stroke: a prospective cohort study.Neurological research and practice · 2026Article
- The Correlations of Clinical Outcomes and Vascular Morphology With Infarct Patterns in Middle Cerebral Arterial Occlusion.Brain and behavior · 2026Article
- Definition and Application Value of the Cystic Plate.Annals of surgical oncology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecent clinical trials have shown that patients with large ischemic cores have better outcomes with endovascular thrombectomy (EVT) compared with standard medical treatment (SMT) alone. The authors aim to assess whether the relationship between EVT and improvements in clinical outcomes varies depending on the location of the occlusive sites.
methodsThis study is a subgroup analysis conducted within a prospective, nationwide, multicenter registry. The cohort included patients with acute large vessel occlusion in the anterior circulation and an Alberta Stroke Program Early Computed Tomography Score of 0-5 within 24 h from last known well. The authors utilized the adjusted common odds ratio for a shift toward better outcomes on the modified Rankin Scale after EVT compared with SMT alone as the primary outcome. Safety outcomes included symptomatic intracranial hemorrhage (sICH).
resultsA total of 745 patients with large ischemic cores were included: 272 (36.5%) with internal carotid artery occlusion, 392 (52.6%) with M1 segment of the middle cerebral artery occlusion, and 81 (11.0%) with M2 segment of the middle cerebral artery occlusion. The adjusted common odds ratios were as follows: 1.98 (95% CI: 1.01-3.89) for ICA occlusions, 2.09 (95% CI: 1.35-3.23) for M1 occlusions, and 1.13 (95% CI: 0.43-2.94) for M2 occlusions. There was no significant treatment-by-occlusion site interaction observed ( P =0.69). However, the incidence of sICH was significantly greater in all groups receiving EVT than in those receiving SMT alone. Additionally, the authors observed that the secondary outcomes and subgroup analyses were generally consistent with the main outcomes.
conclusionsIn this study, the authors found that patients with internal carotid artery and M1 occlusion demonstrated a better outcome with EVT, while the benefit for patients with M2 occlusion remains uncertain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.